Tibolone is not an oestrogen but a mixture of a strong progestin and two weak oestrogens
This important article assesses the overall cancer risk among contemporary menopausal hormone therapy (MHT) users, based on a nationwide Swedish population –based cohort study in 290,186 women using systemic MHT from July 2005 until December 2012.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Herjan JT. Coelingh Bennink Tags: Letter to the Editor Source Type: research
More News: Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Men | Menopause | Study | Sweden Health | Women